Previous close | 11.32 |
Open | 11.42 |
Bid | 11.83 x 600 |
Ask | 11.89 x 1200 |
Day's range | 11.41 - 11.93 |
52-week range | 3.21 - 18.33 |
Volume | |
Avg. volume | 9,046,317 |
Market cap | 3.313B |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Iovance Biotherapeutics, Inc. ( NASDAQ:IOVA ) is possibly approaching a major achievement in its business, so we would...
Iovance (IOVA) surges on the recent FDA approval for its lead pipeline drug as the first individualized, one-time cell therapy for certain patients with melanoma.
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.